Patent search ap:("Janssen Biotech Page Inc.") AND inv:"Mathew Germinaro"

1.

发明申请
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha 审中-公开

公开(公告)号：US20200369761A1

公开(公告)日：2020-11-26

申请号：US16880118

申请日：2020-05-21

Applicant: Janssen Biotech, Inc.

Inventor： Mathew Germinaro , Christopher O'Brien , Jacqueline Perrigoue

IPC: C07K16/24 , A61K9/00 , A61P1/04 , A61P29/00

Abstract: A method of treating inflammatory bowel disorders, such as ulcerative colitis, comprises administering an IL-23 inhibitor, such as an anti-IL-23p19 antibody (e.g., guselkumab) and a TNF-α inhibitor, such as an anti-TNF-α antibody (e.g., golimumab).

2.

发明申请
Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha 有权

公开(公告)号：US20210363234A1

公开(公告)日：2021-11-25

申请号：US17325743

申请日：2021-05-20

Applicant: Janssen Biotech, Inc.

Inventor： Mathew Germinaro , Christopher O'Brien , Jacqueline Perrigoue , Marion Vetter

IPC: C07K16/24 , A61P1/04 , A61P37/02

Abstract: A method of treating inflammatory bowel disorders, such as ulcerative colitis, comprises administering an IL-23 inhibitor, such as an anti-IL-23p19 antibody (e.g., guselkumab) and a TNF-α inhibitor, such as an anti-TNF-α antibody (e.g., golimumab).

Patent Agency Ranking